• Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • Telegram
  • Youtube
  • otv

Tag: Bharat Biotech

 Covaxin
Covaxin 77.8% Effective Against COVID-19: Lancet study

The phase 3 trial Efficacy and Safety Study involving 25,800 volunteers across 25 sites in India is India's largest ever clinical trial conducted for a Covid-19 vaccine.

Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids
Bharat Biotech's US Partner Ocugen Seeks Covaxin Approval For Kids

Covaxin uses the same Vero Cell manufacturing platform as other childhood vaccines, including the inactivated polio vaccine.

Finally Approved!
Covaxin Gets WHO Nod; Union Health Minister’s Reaction

Covaxin Gets WHO Nod; Union Health Minister’s Reaction

Video Icon
Covaxin
Australia Recognises India's Covaxin

This recognition is for travellers aged 12 and over who have been vaccinated with Covaxin, and those 18 to 60 who have been vaccinated with BBIBP-CorV.

Covaxin Approved
Finally, Covaxin Approved For Children In 2-18 Yrs Age Group, DCGI Gives Nod

The Drugs and Comptroller General of India (DCGI) has given a go-ahead to Bharat Biotech's Covaxin for vaccination of children in the 2-18 years age group.

Video Icon
Health Min Releases 1st Commercial Batch Of Covaxin From Bharat Biotech's New Plant
Health Min Releases 1st Commercial Batch Of Covaxin From Bharat Biotech's New Plant

India's vaccination coverage against coronavirus under the mass vaccination drive has crossed the landmark of 63 crore. Over 73 lakh doses have been administered in the last 24 hours.

COVID Vaccine
India May Have COVID19 Vaccines For Children By September Or Just After It: ICMR-NIV

The results of Phase II and III trials of COVAXIN are going on for children in the age group of 2-18 years. So, by September or just after it, we may have COVID-19 vaccines for children, said Priya Abraham, Director of ICMR-NIV

Bharat Biotech Gets Nod For Phase 2/3 Trials Of Intranasal Vaccine
Bharat Biotech Gets Nod For Phase 2/3 Trials Of Intranasal Vaccine

The regulatory approval has been received for conducting "Phase 2 randomised, multi-centric, clinical trial of heterologous prime-boost combination of SARS-CoV-2 vaccines to evaluate the immunogenicity and safety of BBV152 (Covaxin) with BBV154 (Adenoviral Intranasal Covid-19 vaccine) in healthy volunteers.

 Covaxin
Centre Approves Biotech Vax Production Facility At Ankleshwar

India's Covid vaccination coverage has crossed 51 crores cumulatively.

 Covaxin
Review Process Begins For WHO Listing Of Covaxin: Bharat Biotech

The Hyderabad-based company had said in May that that application for EUL was submitted to WHO-Geneva and regulatory approvals are expected by July-September 2021.

No Data To Show Children Will Be Seriously Hit In Next COVID Waves: AIIMS chief
Serum Institute To Conduct Clinical Trials Of Novavax For Children

Novavax Inc had announced that NVX-CoV2373, its recombinant nanoparticle protein-based Covid-19 vaccine, demonstrated 100 per cent protection against moderate and severe disease, 90.4 per cent efficacy overall.

Covaxin Effective For 9-12 Months, No Serious Side-Effects So Far: AIIMS
Bharat Biotech Supplies Covaxin To 16 States

Bharat Biotech dispatched its Covid-19 vaccine Covaxin to nine states through the government of India and to 16 states through the respective state governments.

Covaxins Phase-3 Trials Begin: Bharat Biotech
Working For Full US FDA Approval Of Covaxin: Bharat Biotech

The FDA had on Thursday recommended Ocugen, the US partner of the Indian vaccine maker, to "pursue a Biologics Licence Application (BLA) submission instead of an EUA application" and "requested additional information and data".

Covaxin
Bharat Biotech Supplying Covaxin To 18 States Including Odisha

Bharat Biotech has been directly supplying its Covid-19 vaccine Covaxin to 18 states since May 1

COVAXIN
COVID-19 Fight: Bharat Biotech Begins Covaxin Supplies To 14 States

Bharat Biotech has started direct supplies of its Covid-19 vaccine Covaxin to 14 states.

Covaxin Price Slashed To Rs 400/Dose For States
Covaxin Price Slashed To Rs 400/Dose For States

Bhubaneswar: A day after Serum Institute of India reduced Covishield vaccine price for States to Rs 300 per dose as a philanthropic gesture, Bharat Biotech also slashed the price of…

COVID19 Vaccine: Covaxin Price Fixed At Rs 600 For States, Rs 1,200 For Pvt Hospitals
COVID19 Vaccine: Covaxin Price Fixed At Rs 600 For States, Rs 1,200 For Pvt Hospitals

New Delhi: Bharat Biotech on Saturday said it would provide its COVID-19 vaccine, Covaxin, to state governments at Rs 600 per dosage. The Hyderabad-based vaccine major also said that it would…

Coronavirus
Faster Jabs, Surveillance Can Only Tame Triple-Mutant Indian Virus

New Delhi: Increasing efforts towards faster mass vaccination and virus surveillance is the key to ward off dangers posed by a triple-mutant coronavirus now present in the country, health experts…

Vaccine
Govt To Provide Rs 4,500 Cr Booster To Vaccine Manufacturers For Ramping Up Capacity

New Delhi: Looking to ramp up supplies ahead of the opening of Covid-19 vaccination to all citizens over 18 years of age, the government has approved a payment of about…

United States
Only 311 Of 1.9 Mn Covaxin Beneficiaries Reported Side Effects: Govt

New Delhi: Bharat Biotech’s Covaxin has a negligible number of side effects reported among the beneficiaries of the Covid-19 vaccine, NITI Aayog’s Member (Health), VK Paul said on Thursday. “The vaccine has been administered so far to 19 lakh people and only 311 individuals of them have reported minimal side effects. “It has stood the […]

Bharat Biotech
Covaxin Demonstrates Interim Clinical Efficacy Of 81%

Hyderabad: Bharat Biotech on Wednesday announced the first interim analysis of Covaxin, which shows the efficacy of the Covid-19 vaccine to be at 81 per cent. The Hyderabad-based vaccine maker said whole virion inactivated Covid-19 vaccine candidate demonstrated an interim vaccine efficacy of 81 per cent in its Phase 3 clinical trial. The trials involved […]

vaccines
Covaxin, Covishield New Fact-Sheets: Know Who Can’t Take Vaccines, the Side-effects

Bhubaneswar: With the ‘vaccine hesitancy’ getting manifested in nearly half a dozen districts– including the Capital City– in the State despite a mere 0.01 per cent showing any AEFI (adverse events following immunisation) signs, the two vaccine manufacturers – Bharat Biotech and Serum Institute India – have released fact-sheets that tell who are eligible for […]

55L Covaxin Procured For Rs 206 Per Dose, 1.1 Cr Covidshield Vaccines For Rs 200 A Piece
55L Covaxin Procured For Rs 206 Per Dose, 1.1 Cr Covidshield Vaccines For Rs 200 A Piece

New Delhi: Days before the commencement of the nationwide Covid-19 vaccination drive, the Union Health Ministry said on Tuesday that 1.1 crore Covishield and 55 lakh Covaxin vaccines have been procured at a cost of Rs 200 and Rs 206 per dose, respectively. However, BBIL will provide 16.5 lakh doses of Covaxin free of cost […]

Serum Institute, Bharat Biotech Pledge For Smooth Rollout Of COVID-19 Vaccines
Serum Institute, Bharat Biotech Pledge For Smooth Rollout Of COVID-19 Vaccines

New Delhi: Vaccine makers Serum Institute of India and Bharat Biotech on Tuesday said both the companies jointly pledge for smooth roll out of COVID-19 vaccines in the country and the world. In a show of solidarity after some bitter comments, Adar Poonawala and Krishna Ella, jointly on behalf of Serum Institute and Bharat Biotech, […]

COVID-19 Vaccine: Bharat Biotech Dispatches 1st Batch Of Covaxin For Immunisation Drive
COVID-19 Vaccine: Bharat Biotech Dispatches 1st Batch Of Covaxin For Immunisation Drive

New Delhi: Hyderabad-based Bharat Biotech has sent the first batch of its Covid vaccine, Covaxin, to the government for further distribution as the immunisation drive in the country is set to start in coming days, its CMD Dr Krishna Ella said on Monday. “We have already sent the batch to the Central Research Institute in […]

scrollToTop